AbbVie stockholders may tender all or a portion of their shares at a price specified by the tendering stockholder within this range. When the tender offer expires, AbbVie will determine the lowest price within the range of prices specified above that allows AbbVie to purchase up to an aggregate of $7.
5 billion of its common stock.AbbVie Commences Self-Tender Offer for Up to $7.5 Billion of its Common Stock
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться